{"id":9770,"date":"2023-03-14T07:13:03","date_gmt":"2023-03-14T07:13:03","guid":{"rendered":"https:\/\/staging.grindeks.eu\/?p=9770"},"modified":"2023-03-14T07:13:11","modified_gmt":"2023-03-14T07:13:11","slug":"veselibas-ministre-apmekle-grindeks-razotnes-un-tiekas-ar-uznemuma-vadibu","status":"publish","type":"post","link":"https:\/\/grindeks.com\/lv\/veselibas-ministre-apmekle-grindeks-razotnes-un-tiekas-ar-uznemuma-vadibu\/","title":{"rendered":"Vesel\u012bbas ministre apmekl\u0113 Grindeks ra\u017eotnes un tiekas ar uz\u0146\u0113muma vad\u012bbu"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Marta ievad\u0101 akciju sabiedr\u012bbu Grindeks apmekl\u0113ja LR Vesel\u012bbas ministre L\u012bga Me\u0146\u0123elsone un kop\u0101 ar Grindeks padomes priek\u0161s\u0113d\u0113t\u0101ju Kirovu Lipmanu un valdes priek\u0161s\u0113d\u0113t\u0101ju Juri Hme\u013c\u0146icki apmekl\u0113ja Akt\u012bvo farmaceitisko vielu ra\u017eotni un Gatavo z\u0101\u013cu formu ra\u017eotni.<\/p>\n\n\n\n

Tik\u0161an\u0101s laik\u0101 Vesel\u012bbas ministre un Grindeks vad\u012bbas p\u0101rst\u0101vji diskut\u0113ja par  vesel\u012bbas apr\u016bpes un farm\u0101cijas nozares att\u012bst\u012bbu valst\u012b, viet\u0113jo z\u0101\u013cu ra\u017eot\u0101ju lomu medikamentu tr\u016bkuma nov\u0113r\u0161anai, k\u0101 ar\u012b Grindeks strat\u0113\u0123iju Latvij\u0101 un pasaul\u0113.<\/p>\n\n\n\n

LR Vesel\u012bbas ministre L\u012bga Me\u0146\u0123elsone, apmekl\u0113jot ra\u017eotnes, p\u0101rliecin\u0101j\u0101s, ka Latvijas farm\u0101cijas r\u016bpniec\u012bbai ir ilgtsp\u0113j\u012bga n\u0101kotne, kas ir ieguvums Latvijas sabiedr\u012bbai un valstij kopum\u0101.<\/p>\n\n\n\n

Invest\u012bcijas atmaks\u0101jas<\/strong><\/h3>\n\n\n\n

Vien 2021. gad\u0101 Grindeks akt\u012bvo farmaceitisko vielu ra\u017eotn\u0113 invest\u0113tie 800 t\u016bksto\u0161i eiro un uzst\u0101d\u012bt\u0101s jaun\u0101s laboratorijas un r\u016bpniecisk\u0101s ra\u017eo\u0161anas tehnolo\u0123isk\u0101s iek\u0101rtas, \u013c\u0101va vienam no vienpadsmit iecirk\u0146iem k\u013c\u016bt par multifunkcion\u0101lu.<\/p>\n\n\n\n

P\u0113c veiktaj\u0101m invest\u012bcij\u0101m iecirkni izmanto gan jaunu akt\u012bvo farmaceitisko vielu izstr\u0101des procesiem, gan \u0161o vielu ra\u017eo\u0161anai sav\u0101m vajadz\u012bb\u0101m \u2013 gatavo z\u0101\u013cu ra\u017eo\u0161anai, k\u0101 ar\u012b eksportam. Iecirkn\u012b ir iesp\u0113ja str\u0101d\u0101t ar iek\u0101rt\u0101m, kuru tilpums ir no 100ml l\u012bdz 20l, kas at\u013cauj ra\u017eot da\u017e\u0101das akt\u012bv\u0101s vielas no miligramiem l\u012bdz pat kilogramiem.<\/p>\n\n\n\n

Darbinieku dro\u0161\u012bba pirmaj\u0101 viet\u0101<\/strong><\/h3>\n\n\n\n

Lai r\u016bp\u0113tos par darbinieku dro\u0161\u012bbu un vides aizsardz\u012bbu, multifunkcionalaj\u0101 iecirkn\u012b uzst\u0101d\u012bts ra\u017eo\u0161anas specifikai atbilsto\u0161s pazemin\u0101ta spiediena izolators ar filtr\u0113\u0161anas sist\u0113m\u0101m, kas ne\u013cauj augsti efekt\u012bv\u0101m akt\u012bvaj\u0101m farmaceitiskaj\u0101m viel\u0101m nok\u013c\u016bt saskar\u0113 ar cilv\u0113kiem un apk\u0101rt\u0113jo vidi. Telp\u0101 uzst\u0101d\u012bta ar\u012b m\u016bsdien\u012bga uzraudz\u012bbas un komunik\u0101cijas sist\u0113ma \u0101trai rea\u0123\u0113\u0161anai nestandarta situ\u0101ciju gad\u012bjum\u0101. K\u0101 farm\u0101cijas jomas dal\u012bbnieks Grindeks uzsver augsto atbild\u012bbas l\u012bmeni un uzskata, ka dro\u0161\u012bbas jaut\u0101jumi ir priorit\u0101te visos l\u012bme\u0146os.<\/p>\n\n\n\n

Ra\u017eo\u0161anas jaudas palielin\u0101\u0161anu nosaka augo\u0161ais piepras\u012bjums p\u0113c medikamentiem<\/strong><\/h3>\n\n\n\n

Lai nodro\u0161in\u0101tu augo\u0161o piepras\u012bjumu p\u0113c medikamentiem, Grindeks Gatavo z\u0101\u013cu ra\u017eotn\u0113 ir uzst\u0101d\u012bjis ar\u012b jaunu z\u0101\u013cu kapsul\u0113\u0161anas iek\u0101rtu, kas \u013cauj iev\u0113rojami uzlabot kapsulu ra\u017eo\u0161anas tempus. <\/p>\n\n\n\n

L\u012bdz ar iek\u0101rtas uzst\u0101d\u012b\u0161anu Grindeks kapsulu ra\u017eo\u0161anas jauda ir palielin\u0101jusies par 33%, sasniedzot 750 miljonus kapsulu gad\u0101. Pateicoties jaun\u0101s iek\u0101rtas precizit\u0101tei un darb\u012bbas \u0101trumam, Grindeks ir iev\u0113rojami uzlabojis savu darb\u012bbas efektivit\u0101ti, nodro\u0161inot pacientus ar piepras\u012btaj\u0101m z\u0101l\u0113m.<\/p>\n\n\n\n

Pan\u0101kumu atsl\u0113ga ir pacientu vajadz\u012bbu izpratne <\/strong><\/h3>\n\n\n\n

Grindeks koncerns p\u0113d\u0113jos gados strauji aug un ir p\u0101rliecin\u0101ts, ka at\u0161\u0137ir\u012bb\u0101 no pasaules farm\u0101cijas tirgus l\u012bderiem, tas sp\u0113j \u0101tri un elast\u012bgi rea\u0123\u0113t uz pacientu vajadz\u012bb\u0101m un piepras\u012bjumu. Uz\u0146\u0113mumos norit z\u0101\u013cu izstr\u0101des procesi, zin\u0101\u0161anu p\u0101rnese un past\u0101v\u012bga infrastrukt\u016bras att\u012bst\u012bba, lai papla\u0161in\u0101tu medikamentu un akt\u012bvo farmaceitisko vielu produktu portfeli.<\/p>\n\n\n\n

Grindeks padomes priek\u0161s\u0113d\u0113t\u0101js Kirovs Lipmans uzsver z\u0101\u013cu ra\u017eo\u0161anas noz\u012bmi Latvij\u0101: \u201cM\u016bsu valst\u012b ir sp\u0113c\u012bga farm\u0101cijas industrija, kura ir strauji att\u012bst\u012bjusies, pateicoties profesion\u0101\u013cu augstajai kvalifik\u0101cijai un veiktaj\u0101m invest\u012bcij\u0101m. Ieguld\u012bjumi Grindeks att\u012bst\u012bb\u0101 ir m\u0113r\u0101mi simtos milj. eiro, sniedzot  milz\u012bgu ieguvumu nacion\u0101lajai farm\u0101cijas nozarei un pacientiem Latvij\u0101 un citur pasaul\u0113.\u201d Padomes priek\u0161s\u0113d\u0113t\u0101js ar\u012b atz\u012bm\u0113ja, ka labv\u0113l\u012bga attieksme pret uz\u0146\u0113mumiem ir svar\u012bga valstisk\u0101 l\u012bmen\u012b, it \u012bpa\u0161i pret tiem, kas ra\u017eo produktus ar augstu pievienoto v\u0113rt\u012bbu.<\/p>\n\n\n\n

Tik\u0161an\u0101s laik\u0101 tika diskut\u0113ts par Grindeks att\u012bst\u012bbas iecer\u0113m, terapeitisko grupu un virzienu priorit\u0101t\u0113m. Grindeks var un v\u0113las b\u016bt atbalsts pacientiem, padarot vi\u0146u dz\u012bvi vesel\u012bg\u0101ku un viegl\u0101ku. Izmantojot gadiem uzkr\u0101to pieredzi, Grindeks strat\u0113\u0123iski fokus\u0113jas uz jaunu produktu izstr\u0101di un ievie\u0161anu, k\u0101 ar\u012b uz eso\u0161o z\u0101\u013cu pilnveidi, proti, \u0113rt\u0101k\u0101m lieto\u0161anas form\u0101m, efekt\u012bv\u0101ku z\u0101\u013cu iedarb\u012bbu, devu daudzveid\u012bbu u.tml. Uz\u0146\u0113mumam ir milz\u012bgs potenci\u0101ls pied\u0101v\u0101t saviem pacientiem vienk\u0101r\u0161us un vienlaikus inovat\u012bvus risin\u0101jumus vesel\u012bbas un dz\u012bves kvalit\u0101tes uzlabo\u0161anai, k\u0101 ar\u012b b\u016bt par re\u0101lu Latvijas vesel\u012bbas apr\u016bpes un ekonomikas balstu.<\/p>\n\n\n\n

No viet\u0113j\u0101 z\u0101\u013cu ra\u017eot\u0101ja Grindeks k\u013c\u016bst par starptautisku farm\u0101cijas koncernu<\/strong><\/h3>\n\n\n\n

V\u0113l 2020. gad\u0101 Grindeks izstr\u0101d\u0101ja vid\u0113ja un ilgtermi\u0146a strat\u0113\u0123ijas l\u012bdz 2025. un 2035. gadam. Viens no att\u012bst\u012bbas strat\u0113\u0123ijas virzieniem ir eksporta palielin\u0101\u0161ana jaunajos tirgos \u2013 Eiropas Savien\u012bbas valst\u012bs, ASV, Jap\u0101n\u0101, Dienvidkorej\u0101, Austr\u0101lij\u0101, \u0160veic\u0113 un Kan\u0101d\u0101. Otrs att\u012bst\u012bbas virziens ir produktu kl\u0101sta palielin\u0101\u0161ana, ik gadu iesniedzot re\u0123istr\u0101cij\u0101 ne maz\u0101k k\u0101 18 produktu.<\/p>\n\n\n\n

Grindeks koncerna galvenie darb\u012bbas virzieni ir ori\u0123in\u0101lproduktu, patentbr\u012bvo medikamentu un akt\u012bvo farmaceitisko vielu p\u0113tniec\u012bba, izstr\u0101de, ra\u017eo\u0161ana un p\u0101rdo\u0161ana. Glob\u0101lo ekspansiju apstiprina t\u0101 eksporta sp\u0113ja \u2013 2022. gad\u0101 koncerna z\u0101les izv\u0113l\u0113j\u0101s vesel\u012bbas apr\u016bpes speci\u0101listi un pacienti 100 valst\u012bs. Te j\u0101atz\u012bm\u0113, ka Grindeks galven\u0101s terapeitisk\u0101s grupas un virzieni ir kardiolo\u0123ija, centr\u0101l\u0101 nervu sist\u0113ma, onkolo\u0123ija, diab\u0113ts, dermatolo\u0123ija un akt\u012bv\u0101s farmaceitisk\u0101s vielas. Meitas uz\u0146\u0113muma Kalceks specializ\u0101cija ir medikamenti slimn\u012bcu segmentam un oftalmolo\u0123ija. Grindeks koncerna ra\u017eotnes atrodas Latvij\u0101, Igaunij\u0101 un Slov\u0101kij\u0101. Koncern\u0101 str\u0101d\u0101 1445 darbinieki.<\/p>\n","protected":false},"excerpt":{"rendered":"

Marta ievad\u0101 akciju sabiedr\u012bbu Grindeks apmekl\u0113ja LR Vesel\u012bbas ministre L\u012bga Me\u0146\u0123elsone un kop\u0101 ar Grindeks padomes priek\u0161s\u0113d\u0113t\u0101ju Kirovu Lipmanu un valdes priek\u0161s\u0113d\u0113t\u0101ju Juri Hme\u013c\u0146icki apmekl\u0113ja…<\/p>\n","protected":false},"author":6,"featured_media":9785,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9770","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/9770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=9770"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/9770\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/9785"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=9770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=9770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=9770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}